Virginia STEM News
SEE OTHER BRANDS

Daily news on science and technology in Virginia

Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on May 7, 2025

Local Medical Billing Company Expands Nationwide with Human-Centered Solutions

Local Medical Billing Company Expands Nationwide with Human-Centered Solutions

Meddy expands nationwide as more providers seek billing partners who combine technology with trusted, long-term human support. FAIRFAX, VA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- With medical billing complexity and administrative costs on the …

Scout Space Awarded TACFI Contract to Deliver New GEO Space Domain Awareness Sensor to U.S. Space Force

Scout Space Awarded TACFI Contract to Deliver New GEO Space Domain Awareness Sensor to U.S. Space Force

Advancing the Company’s GEO Sensor Networks Program RESTON, VA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Scout Space Inc., a leading in-space observation service provider focused on space security and comprehensive Space Domain Awareness (SDA), …

Scout Space Awarded TACFI Contract to Enhance Space Domain Awareness via On-Board Data Processing for U.S. Space Force

Scout Space Awarded TACFI Contract to Enhance Space Domain Awareness via On-Board Data Processing for U.S. Space Force

Augmenting Tactical Intelligence Using On-Board Data Processing RESTON, VA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Scout Space Inc., a leading in-space observation service provider focused on space security and comprehensive Space Domain …

Dexian Releases 2025 Work Futures Study: AI Momentum Exposes Talent Readiness Gap

Dexian Releases 2025 Work Futures Study: AI Momentum Exposes Talent Readiness Gap

New research explores how emerging technologies and evolving worker priorities are reshaping the employment landscape. MCLEAN, VA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Dexian, a leading provider of talent and technology solutions, today …

Grenova Expands International Operations with New Facility in Mannheim, Germany

Grenova Expands International Operations with New Facility in Mannheim, Germany

Grenova opens a new facility in Mannheim, Germany, expanding its global reach and supporting sustainable lab solutions for customers across Europe. RICHMOND, VA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Grenova, a leader in sustainable lab …

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) --  Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …

MKS Instruments Reports First Quarter 2025 Financial Results

MKS Instruments Reports First Quarter 2025 Financial Results

Quarterly revenue of $936 million, at the high end of guidance Quarterly GAAP net income of $52 million and net income per diluted share of $0.77, each above the midpoint of guidance Quarterly Adjusted EBITDA of $236 million, at the high end of guidance, …

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025     — Streamlining operations and focusing on delivering potential value generating program milestones, with …

ESCO Reports Second Quarter Fiscal 2025 Results

ESCO Reports Second Quarter Fiscal 2025 Results

St. Louis, May 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2025 (Q2 2025). Operating Highlights Q2 2025 Sales increased $16.4 million (7 …

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

SiTime Reports First Quarter 2025 Financial Results

SiTime Reports First Quarter 2025 Financial Results

SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the first quarter ended March 31, 2025. Net revenue in the first quarter of 2025 was $60.3 million …

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …

Veeco Announces Over $35 Million in Advanced Packaging Lithography System Orders From IDM & OSAT Customers

Veeco Announces Over $35 Million in Advanced Packaging Lithography System Orders From IDM & OSAT Customers

PLAINVIEW, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced its received over $35 million of orders for its AP300™ Lithography systems in recent quarters from a wide-range of IDM and OSAT customers. The orders …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

Fortinet Reports First Quarter 2025 Financial Results

Fortinet Reports First Quarter 2025 Financial Results

Highlights Total revenue of $1.54 billion, up 14% year over year Product revenue of $459 million, up 12% year over year Billings of $1.60 billion, up 14% year over year1 Unified SASE ARR2 up 26% and Security Operations ARR2 up 30%, year over year Record …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service